NCT06682780 2025-09-25A Phase I/II Study of LM-2417 in Subjects With Advanced Solid TumoursLaNova Medicines LimitedPhase 1/2 Recruiting320 enrolled
NCT05014828 2025-08-24To Evaluate the Efficacy and Safety of Tislelizumab in Combination With Lenvatinib in Participants With Selected Solid TumorsBeiGenePhase 2 Completed58 enrolled 16 charts